These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 10993017)

  • 1. [Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure].
    Di Lenarda A
    Ital Heart J Suppl; 2000 Aug; 1(8):1063-5. PubMed ID: 10993017
    [No Abstract]   [Full Text] [Related]  

  • 2. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
    Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J;
    J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
    Gullestad L; Wikstrand J; Deedwania P; Hjalmarson A; Egstrup K; Elkayam U; Gottlieb S; Rashkow A; Wedel H; Bermann G; Kjekshus J;
    J Am Coll Cardiol; 2005 Jan; 45(2):252-9. PubMed ID: 15653024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
    Deedwania PC; Giles TD; Klibaner M; Ghali JK; Herlitz J; Hildebrandt P; Kjekshus J; Spinar J; Vitovec J; Stanbrook H; Wikstrand J;
    Am Heart J; 2005 Jan; 149(1):159-67. PubMed ID: 15660048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.
    Hjalmarson A; Goldstein S; Fagerberg B; Wedel H; Waagstein F; Kjekshus J; Wikstrand J; El Allaf D; Vítovec J; Aldershvile J; Halinen M; Dietz R; Neuhaus KL; Jánosi A; Thorgeirsson G; Dunselman PH; Gullestad L; Kuch J; Herlitz J; Rickenbacher P; Ball S; Gottlieb S; Deedwania P
    JAMA; 2000 Mar; 283(10):1295-302. PubMed ID: 10714728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
    Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MERIT-HF mortality and morbidity data.
    Hjalmarson A; Fagerberg B
    Basic Res Cardiol; 2000; 95 Suppl 1():I98-103. PubMed ID: 11192362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF.
    Jánosi A; Ghali JK; Herlitz J; Czuriga I; Klibaner M; Wikstrand J; Hjalmarson A;
    Am Heart J; 2003 Oct; 146(4):721-8. PubMed ID: 14564329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
    Terra SG; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hamilton KK; Aranda JM; Hill JA; Yarandi HN; Walker JR; Phillips MS; Gelfand CA; Johnson JA
    Clin Pharmacol Ther; 2005 Mar; 77(3):127-37. PubMed ID: 15735607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained restoration of autonomic balance with long- but not short-acting metoprolol in patients with heart failure.
    Aquilante CL; Terra SG; Schofield RS; Pauly DF; Hatton PS; Binkley PF; Johnson JA
    J Card Fail; 2006 Apr; 12(3):171-6. PubMed ID: 16624680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure.
    Deedwania PC; Gottlieb S; Ghali JK; Waagstein F; Wikstrand JC;
    Eur Heart J; 2004 Aug; 25(15):1300-9. PubMed ID: 15288157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blockers and heart failure.
    Health News; 2000 Apr; 6(4):8. PubMed ID: 15356892
    [No Abstract]   [Full Text] [Related]  

  • 13. The merit of beta(1)-blockade in heart failure.
    Fagerberg B
    Eur Heart J; 1999 Dec; 20(24):1761-3. PubMed ID: 10581129
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of metoprolol CR/ZOK in the cardiological practice].
    Podzolkov VI; Samoĭlenko VV; Osadchiĭ KK; Strizhakov LA
    Ter Arkh; 2000; 72(9):78-80. PubMed ID: 11076427
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of metoprolol CR/XL on mortality and hospitalizations in patients with heart failure and history of hypertension.
    Herlitz J; Wikstrand J; Denny M; Fenster P; Heywood T; Masszi G; Rasmussen S; Thorgeirsson G; Wachtell K;
    J Card Fail; 2002 Feb; 8(1):8-14. PubMed ID: 11862577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of metoprolol on beta1 adrenergic receptor polymorphism and receptor density in urban Chinese patients with heart failure.
    Luo M; Bi Y; Xu YX
    Chin Med J (Engl); 2007 Oct; 120(19):1720-3. PubMed ID: 17935678
    [No Abstract]   [Full Text] [Related]  

  • 17. Should beta-blockers form the cornerstone for the treatment of congestive heart failure?
    Tabrizchi R
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):157-60. PubMed ID: 15030275
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-blockers work as well in women as in men.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Apr; 13(7):5-7. PubMed ID: 12452171
    [No Abstract]   [Full Text] [Related]  

  • 19. Statistical issues relating to international differences in clinical trials.
    O'Shea JC; DeMets DL
    Am Heart J; 2001 Jul; 142(1):21-8. PubMed ID: 11431652
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonselective versus selective beta-blockers in the management of chronic heart failure: clinical implications of the carvedilol or Metoprolol European Trial.
    Greenberg B
    Rev Cardiovasc Med; 2004; 5 Suppl 1():S10-7. PubMed ID: 15184835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.